Findacure, a UK-based charity, and Elsevier have joined forces to combat the rare disease, congenital hyperinsulinism (CHI), where newborns have permanently excessive levels of insulin in the blood, which can lead to brain injury or death if not caught quickly. Elsevier is helping Findacure by analyzing the disease’s biological pathways and structure, as well as by looking at already-published literature for further insights into the disease.
- G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs.OBJECTIVE: On the basis of the recently recognized potential of bone marrow (BM) cells to give rise to hepatocytes, we investigated the possibility that granulocyte colony-stimulating factor […]
- Essential Guide to Prostate Health – New Second EditionProblems related to the prostate are among the most common reasons men visit their doctors. Often, this involves benign prostatic hyperplasia (BPH). In fact, as many as half of the men between ages […]
- Most Cited Journal of Traditional and Complementary Medicine ArticlesNon-alcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver injury across the world. It is also strongly related to other pathological conditions, including obesity, […]
- Repurposing Drugs Helps Patients with Rare DiseasesFindacure, a UK-based charity, and Elsevier have joined forces to combat the rare disease, congenital hyperinsulinism (CHI), where newborns have permanently excessive levels of insulin in the blood, […]
- The Operating Room of the Future – InSightec – Dr. Kobi Vortman Technion AlumnusInSightec® is the pioneer and global leader in MR guided Focused Ultrasound Surgery (MRgFUS) . InSightec developed ExAblate, a product which pioneers the use of MRgFUS, and provides a personalized […]
- 604Hi there, just became alert to your blog through Google, and found that it is really informative. I am going to watch out for brussels. I’ll be grateful if you continue this in future. Lots of […]
- Johns Hopkins UpdateAFTER YEARS OF TELLING PEOPLE CHEMOTHERAPY IS THE ONLY WAY TO TRY (‘TRY’, BEING THE KEY WORD) TO ELIMINATE CANCER, JOHNS HOPKINS IS FINALLY STARTING TO TELL YOU THERE IS AN ALTERNATIVE […]